Business
from24/7 Wall St.
2 days agoUBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
UBS upgraded Jazz Pharmaceuticals to Buy with a $307 target, citing resilient franchises, pipeline progress, and valuation upside ahead of zanidatamab PDUFA.